Mostrando 173,481 - 173,500 Resultados de 174,586 Para Buscar '"'39"', tiempo de consulta: 0.95s Limitar resultados
  1. 173481
    “…After modelling using mixed effects, Residence of patients (aOR= 1.31, 95%C: 1.12-1.80), living in houses with more than 6 family members (aOR= 4.15, 95% C: 3.06-5.39), previous close contact with MDR-TB (aOR= 6.03, 95% C: 4.01-8.12), history of TB treatment (aOR= 2.16, 95% C: 1.06-3.42), tobacco consumption (aOR = 3.17 ,95% C: 2.06-5.45) and underlying diabetes’ ( aOR= 4.09,95% CI = 2.01-16.79) were significantly associated with MDR-TB. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  2. 173482
  3. 173483
    “…RÉSULTATS: Nous avons interrogé 32 patients, 9 hommes et 23 femmes (genre ratio : 0,39), d’âge moyen de 52,43 ans [22-75]. Les pathologies les plus fréquentes étaient l’hypertension artérielle (46,67 %), le lupus systémique (33,33 %), le diabète (26,67 %), la maladie de Behçet (16,67 %) et le syndrome de Sjögren (16,67 %). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  4. 173484
    “…Among the allele *10 standard named genotypes, *1/*10, *1/*1 and *2/*10 were significantly more frequent in the NR group ([Formula: see text] = 3.911, P < 0.05) and all showed uncompromised enzyme activity; the impaired genotype *10/*39 was more frequent in the SR group ([Formula: see text] = 10.050, P < 0.05), and genotype *4/*4was detected only in the SR group. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  5. 173485
    “…Our results showed that the ACE2-DD genotype was strongly associated with increased COVID-19 severity (OR 2.37 (95%) CI = (1.19–4.70), RR = 1.39 (1.09–1.77), p < 0.013) and also a strong association was seen with ACE2-ID genotype with COVID-19 severity (OR 2.20 (95%) CI = (1.08–4.46), p < 0.020) in the codominant model. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  6. 173486
    “…RÉSULTATS: D’avril 2020 à juin 2021, des données ont été recueillies auprès de 95 patients âgés de 13,1 ± 4,4 ans, de prédominance féminine (62,1 %), atteints de RMD : une arthrite juvénile idiopathique 44 (46,3 %), maladie auto-inflammatoire 6 (6,3 %), vascularite 1(1,1 %) et maladie systémique auto-immune 37 (39 %), avec un diagnostic hautement suspecté/confirmé de COVID-19. 33 patients (34,7 %) ont reçu des DMARDS, 35 (36,84 %) des bioDMARD,10 (10,6 %) des glucocorticoïdes systémiques et 11(11,7 %) des AINS. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  7. 173487
    “…Parmi les patients ayant mentionné des limites à la réalisation de ces séances (n = 72 ; 39 %), l’éloignement géographique (n = 54 ; 75 %) et les contraintes d’horaires (n = 9 ; 12 %) étaient les principaux freins. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  8. 173488
    “…Computational modeling revealed that patients displayed enhanced reward learning rates (mean difference [MD], 0.21; 95% highest density interval [HDI], 0.04-0.38) but decreased punishment learning rates (MD, −0.29; 95% HDI, −0.39 to −0.18), reinforcement sensitivity (MD, −4.91; 95% HDI, −9.38 to −1.12), and stickiness (MD, −0.35; 95% HDI, −0.57 to −0.11) compared with controls. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  9. 173489
  10. 173490
    “…Incidences per 1000 person-years of symptomatic infections were 25.62 for AZD1222 vs 103.42 for placebo (VE 75.23%; 95% CI 65.33, 82.31) and of asymptomatic infections were 51.24 vs 111.95 (VE 54.24%; 95% CI 39.99, 65.10) (Table). Sensitivity analyses for N seroconversion using the primary endpoint and CDC criteria for defining symptomatic/asymptomatic status were supportive. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  11. 173491
  12. 173492
    “…We estimated the age and sex adjusted annual incidence of CAP overall, and by age groups (0–4, 5–17, 18–39, 40–64, 65–74, 75–84 and ≥85 years) according to routine childhood pneumococcal conjugate vaccine (PCV) immunization periods from 2005–2018 in Ontario and from 2002–2018 in BC. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  13. 173493
    “…There was a strong association between adherence and HIV incidence [among individuals who took < 2, 2−3, 4−6, and ≥7 tablets/week, the HIV IRs (95% CI) were 5.20 (4.03, 6.71), 0.38 (0.12, 1.18), 0.28 (0.12, 0.61), and 0.06 (0.01, 0.39), respectively. Overall IR (95% CI) of HIV infection among cisgender men was 1.25 (0.98, 1.60) per 100 patient-years. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  14. 173494
  15. 173495
    “…Heart rate (25 effect sizes; SMD = 0.05 [95% CI: − 0.09, 0.19]), W(peak) (9 effect sizes; SMD = − 0.12 [95% CI: − 0.39, 0.15]), PCO(2) (11 effect sizes; SMD = 0.07 [95% CI: − 0.14, 0.29]) and VCO(2) (4 effect sizes, SMD = − 0.30 [95% CI: − 0.71, 0.10]) were not different to the control, either in total or dependent on mask type or physical activity status. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  16. 173496
    “…Regression analyses revealed that survivors who received only surgery had lower odds of developing cardiovascular (adjusted odds ratio 0.73 [CI:0.56–0.94]), haematological (aOR 0.51 [CI:0.37–0.70]), immunology and infection (aOR 0.84 [CI:0.71–0.99]) and renal (aOR 0.51 [CI:0.39–0.66]) late effects. By contrast, the opposite trend was observed in survivors who received chemo-radiotherapy. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  17. 173497
    “…We have investigated the humoral and T-cell response of 39 patients with MDS two to four weeks following Covid-19 booster vaccination with BNT162b2 or ChAdOx1 nCoV-19 through the SOAP study (Sars-cov-2 fOr cAncer Patients, IRAS project ID:282337). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  18. 173498
  19. 173499
    por Gonzalez-Ochoa, Alejandro
    Publicado 2021
    “…Fewer patients required oxygen support in the sulodexide group [39 of 155 vs. 56 of 157; RR, 0.61; 95% CI, 0.38 to 0.9; p=0.04], and for fewer days (9 ± 7.2 in the sulodexide group vs. 11.5 ± 9.6 in the placebo group; p=0.02). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  20. 173500
Herramientas de búsqueda: RSS